Industry News

Stryker agrees to buy Invuity for $190m

13/09/2018

Stryker has agreed to acquire medical technology company Invuity in a cash deal valued at approximately $190m.

More...

Diabetes company named as one of UK's top 100 tech firms

12/09/2018

GlucoRx was ranked 70th in the Sunday Times Hiscox Tech Track 100 league table for its fast growth over the last three years, which saw it record a sales growth of 66%. The company is one of seven in the south east of England which has seen its sales grow by an average of 136% a year and collectively total £120 million.

More...

BTG buys vascular devices firm Novate Medical

11/09/2018

UK-based healthcare company BTG has acquired Irish medical devices maker Novate Medical to bolster its position in the vascular market.

More...

'Invisible scalpel' treats chronic pain without incision

30/07/2018

An ‘invisible scalpel’ has been developed to help physicians deliver treatments directly at the point of injury, without ever needing to cut into the patient.

More...

Ethicon Looks to Innovation in Quest to Reduce Thoracic Surgery Complications

30/07/2018

Ethicon points to its innovations during a symposium at this year’s 26th European Society of Thoracic Surgeons, linking its advances with improved patient outcomes and lowered hospital costs.

More...

University trains AI to analyse cancer images

30/07/2018

A team from the University of Jyväskylä state that they have taken the first step towards developing a digital service centre based on artificial intelligence where doctors and pathologists analyse tumour tissue samples visually with the help of software.

More...

First AI system for the operating room launches

20/07/2018

The first real-time, artificial intelligence-based (AI) system has been developed for use in the operating room by healthtech company, Digital Surgery.

More...

Medtronic receives FDA approval for less invasive heart failure device

20/07/2018

Medtronic has received FDA approval for a device designed for a less invasive approach for patients with advanced heart failure. The company’s HVAD System is a left ventricular assist device (LVAD) which helps the heart pump and increase the amount of blood that flows through the body. The system is the smallest commercially available LVAD and the only such device approved in the US for implant via thoracotomy, a small lateral, surgical incision between the patient's ribs on the left side of the chest.

More...

U.S. May Soon Have First Meniscus Implant

20/07/2018

Orthopedic implant specialist, Active Implants, LLC, tells us the final patient was treated in the two clinical trials evaluating the NUsurface® Meniscus Implant.

More...

Boston Scientific wins third Mass. pelvic mesh trial

25/06/2018

Boston Scientific (NYSE:BSX) last week won the third Massachusetts trial of a product liability lawsuit brought over two of its pelvic mesh products.

More...

Philips acquires Remote Diagnostic Technologies

25/06/2018

Royal Philips (NYSE:PHG) said on 15 June it acquired U.K.-based Remote Diagnostic Technologies for an undisclosed amount.

More...

HPV vaccine cuts cancer-causing infection

20/06/2018

There has been a significant fall in the number of cases of HPV, the virus that causes cervical cancer, following the introduction of a vaccine for young women, a new study says.

More...

FDA Clearance Expands Scalp Cooler Indication

20/06/2018

The Paxman Scalp Cooling System has now been cleared by the US FDA for use during treatment of patients with solid tumours.

More...

French medtech company develops AI to help treat atrial fibrillation

20/06/2018

A French medtech company has developed AI software to help cardiologists treat atrial fibrillation (AF) and cardiac surgeons perform heart surgery.

More...

Super Sensitive, AI Powered Drill for Safe Access Into Middle Ear

08/06/2018

At Brunel University London in the UK, researchers have developed a remarkable surgical drill for drilling into the cochlea. The device is intended to help with placement of cochlear implants, devices that stimulate the cochlear nerve and return to people with profound hearing loss the ability to hear again.

More...

NHS Trust uses 3D printing for two-year old's life-saving kidney operation

04/06/2018

A London NHS Trust has used 3D printing to help surgeons successfully transplant a father’s kidney into his two-year old son.

More...

Endoscopic robot gets first clinical use

04/06/2018

Munich-based surgical robotics startup Medineering has announced that an endoscopic robot developed by the group has now been put to clinical use.

More...

New WatchPAT™ Sleep Apnea Scoring Guidelines Unveiled at SLEEP 2018

04/06/2018

Diagnostic device company, Itamar Medical Ltd., is to unveil its WatchPAT Scoring Guidelines, a streamlined approach for reviewing and editing WatchPAT™ data that integrates automated scoring with visual oversight for sleep apnea testing.

More...

UK AI start-up raises £10M to speed up diagnosis of coronary disease

24/05/2018

A UK artificial intelligence (AI) start-up that has developed technology for the diagnosis of coronary disease has raised £10 million investment.

More...

Medical devices developed to assist doctors with disabilities

24/05/2018

Instead of using a traditional stethoscope or otoscope to examine a patient, one physician-in-training at the University of Michigan uses a new device, with a long, flexible wire and camera at its tip. A live video feed plays important diagnostic information back on her cell phone. The specially created device allows this medical student to overcome the challenges of performing standard patient examinations with limited mobility.

More...

Diabetes blood test 'could mean end to daily insulin jabs'

17/05/2018

Doctors in Edinburgh believe a simple blood test they have introduced could allow some Type 1 diabetes patients to come off insulin.

More...

Powered Stapler Yields Fewer Bleeding Complications in Lung Cancer Surgery

17/05/2018

A new study showed a near 50% reduction in bleeding complications when comparing powered vs manual stapler during video-assisted thoracoscopic surgery (VATS) for lung cancer. It also found a nearly 10 percent reduction in total hospital costs and one day sooner discharge from the hospital associated with the powered-stapling procedures.

More...

Renishaw surgical robot assists with neurosurgery at Liverpool NHS Trust

17/05/2018

Neurosurgeons at the Walton Centre carried out their first two stereoelectroencephalography (SEEG) procedures with the assistance of the Renishaw neuromate stereotactic robot.

More...

'Black box' call for medical devices to detect errors

01/05/2018

Medical devices and computers should have a black box style feature similar to aircraft to investigate whether errors have contributed to patient harm, an IT expert has said.

More...

Method to map craters on Mars used to assess tumours

30/04/2018

A method used to map the surface of Mars has been adapted to help scientists measure the effects of treatments on tumours.

More...

First Cases for Acclarent TruDi ENT Navigation System

30/04/2018

J&J’s Acclarent, Inc., a leader in developing minimally-invasive Ear, Nose & Throat (ENT) technologies, has announced the U.S. commercial launch of TruDi, a real-time, three-dimensional (3D) navigation system for ENT procedures performed in the operating room and surgeon office.

More...

Novartis launches app to revolutionise patient experience in clinical trials

30/04/2018

Pharmaceutical company Novartis has launched an ophthalmic digital research app to help researchers track disease progression.

More...

Biodegradable silk fibres could help bones heal

23/04/2018

Researchers from the University of Connecticut have developed a biodegradable composite made from silk fibres that can be used to repair load-breaking broken bones safely and effectively.

More...

Google combines augmented reality with deep learning to spot cancer

23/04/2018

A team of Google researchers has developed a tool that combines augmented reality (AR) with a deep learning neural network that can help pathologists to spot cancerous cells on slides under a microscope.

More...

Revolutionary ‘Nanotech’ Solution to Global Antimicrobial Resistance Crisis

23/04/2018

A British nanotechnology company has created a potentially game-changing technology that aims to overcome the global threat of antibiotic resistance.

More...

Hitachi to trial world’s first urine cancer detection test

19/04/2018

Japanese engineering and IT firm Hitachi plans to carry out what it claims to be the world’s first experiment to test for cancer using urine samples.

More...

WATS3D Increases Detection of Pre-Cancerous Changes in the Esophagus by Over 80%

19/04/2018

A newly published study says that adjunctive use of the CDx Diagnostics WATS3D tissue sampling and analysis system increases the detection of both Barrett’s esophagus and esophageal dysplasia by over 80%.

More...

Portable chest drain could save NHS £8.5M every year

19/04/2018

The National Institute for Health and Care Excellence (NICE) has issued medical technology guidance recommending Medela’s Thopaz+ for managing chest drains.

More...

Tech to transform hospitals by 2030, reports states

11/04/2018

The future of healthcare could be with us within 10 years according to a new report which states that sensors, cameras and robotic scanning devices might make up more of our interactions than with doctors and nurses.

More...

Interview with Tal Golesworthy, Inventor of the ExoVasc Aortic Root Support

11/04/2018

Medgadget have recently published a very interesting interview with Tal Golesworthy. Medgadget editor Tom Peach spoke with Tal Golesworthy to hear about the inspiring journey that gave birth to the ExoVasc and to learn more about Exstent, the company that was formed as a result of Tal’s invention.

More...

Cardiac imaging technique shortens testing time and improves accuracy

11/04/2018

A new technique for conducting cardiac MRI imaging tests can improve patient comfort, shorten testing times and could increase diagnostic accuracy and reliability.

More...

Brexit report calls to place UK as global innovation hub

03/04/2018

A new report on Brexit has been published by advocacy group, Campaign for Science and Engineering (CaSE), with questions on policy from the science and engineering sector.

More...

Researchers develop 3D printed stomach monitor

03/04/2018

A team of researchers from the University of California at Berkeley and the University of California at San Diego have created a 3D printed wearable stomach monitor.

More...

Boston Scientific Announces Acquisition of Securus Medical Group, Inc.

03/04/2018

Acquisition strengthens electrophysiology cardiac ablation portfolio with thermal monitor. 

More...

First Patient in Biosense Webster’s Multi-Electrode RF Balloon Catheter Study

26/03/2018

Heart arrhythmia specialist company, Biosense Webster, Inc., has enrolled and treated the first patient in Europe to its SHINE  clinical study.

More...

Wearable sensor could be painless solution to blood tests

26/03/2018

By measuring the chemical composition of peoples’ sweat, the researchers believe clinicians could diagnose and monitor chronic conditions such as diabetes, kidney disease and some types of cancer, without the need for invasive blood tests.

More...

Stryker wins Deal of the Year for buying Novadaq

22/03/2018

Stryker Corp.’s (Nasdaq: SYK) $700 million purchase of surgical imaging technology provider Novadaq, signals the medical device maker’s prowess in wielding M&A not just to grow existing businesses but also to enter new markets.

More...

Enrollment Complete in Thermocool Smarttouch® SF Catheter US IDE Study

19/03/2018

Heart arrhythmia specialist company, Biosense Webster, Inc., has completed patient enrollment in its U.S. IDE study of the THERMOCOOL SMARTTOUCH® SF Catheter. The device is designed for the treatment of persistent atrial fibrillation (AF), an irregular heartbeat that lasts beyond seven days.

More...

Alzheon files for $81M IPO to fund phase 3 Alzheimer’s trial

19/03/2018

Alzheon is looking to tap public investors for $81 million to take a beta amyloid Alzheimer’s drug into phase 3. The Nasdaq IPO will equip Alzheon to take its reworking of a once-failed drug into a pivotal clinical trial in a subset of Alzheimer’s patients later this year.

More...

Junior doctors launch app to ease pressure on NHS

19/03/2018

A group of NHS doctors have launched an app to help the way clinical staff communicate with each other and to ease the current pressures on the organisation.

More...

Another AAOS Launch: United Orthopedic Corporation’s UTS™ Hip Stem

08/03/2018

United Orthopedic Corporation is at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in New Orleans where it has launched the UTS™ hip stem and an extension of the U-Motion II™ Acetabular System.

More...

ItoM Medical launched for wearables diagnostics market

08/03/2018

Design service company, Semiconductor Ideas to the Market (ItoM), is expanding into the wearable biometrics market with the launch of its new sister company, ItoM Medical.

More...

Novartis becomes deeper Science 37 partner, as pair aim for 10-trial launch

08/03/2018

Big Pharma Novartis is teaming up with virtual clinical trial company Science 37 to boost the Swiss major’s ability to run “site-less” studies.

More...

Pancreatic stem cell discovery opens door to regenerative treatments for diabetes

02/03/2018

The transplantation of insulin-producing islets has helped some patients live without the need for insulin injections, but there are not enough cells to treat the millions of people who have Type 1 diabetes. A regenerative solution could bridge this gap.

More...

UK trio team up on life-saving baby device

02/03/2018

Three members of Medilink East Midlands (EM) have joined together in the creation of an innovative baby health product that could save millions of lives.

More...

Simplify Medical Celebrates 50th U.S. Patent

02/03/2018

Simplify Medical Pty Ltd, tells us it has received a 50th U.S. patent for its innovative cervical motion preservation intellectual property (IP) portfolio.

More...

Endologix Completes ELEVATE IDE Clinical Study Enrollment

16/02/2018

Aortic stent Graft innovator Endologix, Inc., tells us it has completed enrollment in the Expanding Patient Applicability with Polymer Sealing Ovation Alto Stent Graft (ELEVATE) IDE clinical study.  The 75-patient study is evaluating the safety and effectiveness of the Alto Abdominal Stent Graft System for the repair of infrarenal abdominal aortic aneurysms (AAAs).

More...

SBRI awards £1M to cancer diagnosis technologies

16/02/2018

The NHS England funded initiative, which aims to bring the latest technology to the UK’s health system, announced that ten companies will share in a £1 million investment.

More...

Novartis, Gates Foundation pen tropical disease drug pact

16/02/2018

The Bill & Melinda Gates Foundation has teamed up with big pharma Novartis and its experimental drug for certain diarrheal diseases.

More...

25,000 U.S. Women Have Experienced Wire-free Breast Tumor Localization with SAVI SCOUT®

05/02/2018

Wire-free breast localization specialist company, Cianna Medical, Inc. has reached something of a milestone: 25,000 breast tumor localizations have been performed with the SCOUT® Radar Localization System.

More...

Could this insect-inspired robot offer a new way for drug delivery?

05/02/2018

A miniature robot inspired by insects and jellyfish has been developed by scientists at the Max Planck Institute for Intelligent Systems that can traverse complex environments to potentially deliver drugs to targeted regions or find use in minimally-invasive surgical procedures.

More...

AstraZeneca stops monotherapy study at centerpiece of $500M buyout

05/02/2018

AstraZeneca has stopped (PDF) monotherapy development of a PD-1 drug it acquired in a $500 million (€400 million) biotech buyout. The candidate, MEDI0680, was the centerpiece of AstraZeneca’s takeover of Amplimmune.

More...

Biogen’s MS drug Tecfidera could make cancer-killing viruses more potent: study

29/01/2018

Cancer-killing viruses, also called “oncolytic” viruses, made their entry into oncology practices in 2015 with the approval of Amgen’s melanoma drug Imlygic, which was derived from herpes. Many other companies are studying a range of viruses as potential cancer remedies—but finding limited success so far.

More...

How AI could be used to prevent diabetes

29/01/2018

The Mealplanner Europe, a Finnish medtech company creating software that plans and organises nutrition for users, and MediSapiens, a developer and provider of genomic, biomedical and health data solutions, have partnered to develop an application for helping users in the prevention of onset of type 2 diabetes. The development is funded by an EU grant from the Permides (Personalised Medicine Innovation through Digital Enterprise Solutions) project.

More...

Neural Analytics Raises $15M for Lucid Brain Monitor Development

29/01/2018

Brain health specialist Neural Analytics, Inc., has raised $15 million to develop its Lucid System to assess and monitor additional brain health conditions.

More...

First Patient Enrolled in U.S. LAA Stroke Study

22/01/2018

Heart Arrhythmia specialist, J&J company, Biosense Webster, Inc. has enrolled the first patient in a study to evaluate the safety and effectiveness of a pioneering Left Atrial Appendage (LAA) closure treatment.

More...

Glucose monitors now compatible with iPhone via Lightning port

22/01/2018

Digital healthtech group DarioHealth has announced the first sales of its Lightning-enabled version of its Dario blood glucose monitoring system in the UK.

More...

Pandion Therapeutics launches with $58M series A

22/01/2018

Pandion Therapeutics, which is developing targeted immune modulator drugs, emerged from stealth mode with a $58 million series A.

More...

Fresh insights into a giant protein could improve heart health

15/01/2018

Titin is the largest protein circulating throughout the human body, and it plays a key role in helping muscles function properly—especially in the heart. Now an international team of researchers has discovered a new mechanism that regulates this protein. The insights could help improve the understanding of the many disease processes that damage the heart.

More...

EU sets aside €4 million for ‘wild card’ healthtech ideas

15/01/2018

As part of its new ‘Wild Card’ initiative, EIT Health has announced €4 million in funding for entrepreneurs, data/IT experts and researchers with ideas to transform European healthcare.

More...

Adapsyn signs $162M microbe-mining deal with Pfizer

15/01/2018

Finding drugs amongst the metabolic soup of living organisms is a tough task, but Canadian biotech Adapsyn Bioscience has developed a system that could sift out promising candidates more quickly—catching the eye of a pharma partner.

More...

Arvinas in $830M-plus Pfizer biobucks deal

08/01/2018

Yale spinout and 2015 Fierce 15 company Arvinas, a biotech working on small-molecule protein degradation therapies, has penned a deal potentially worth $830 million, and more besides, with Big Pharma Pfizer.

More...

UK NICE Updates Endobronchial Valve Treatment to Standard Care

08/01/2018

Pulmonx® Corp. tells us that the UK’s National Institute for Health and Care Excellence (NICE) has updated its guidance for endobronchial valves used to treat severe emphysema, an advanced form of chronic obstructive pulmonary disease (COPD), and now considers current evidence sufficient to support routine use.

More...

Roche to buy Ignyta for $1.7 billion

08/01/2018

Roche has announced plans to buy US group Ignyta for $27 a share in an all-cash deal totaling around $1.7 billion, securing itself access to the latter’s experimental cancer medicines.

More...

Breathe easy: minimally-invasive device could be life-changing for lung patients

02/01/2018

An operation which could benefit patients of all ages has been carried out in Scotland for the first time, at the Golden Jubilee National Hospital.

More...

AbbVie’s JAK1 upadacitinib hits arthritis, but death registered in test

02/01/2018

AbbVie has scored another key trial win with its blockbuster-in-waiting JAK1 inhibitor upadacitinib (ABT-494), but a death and pulmonary embolism take some of the shine off the data.

More...

US Launch of First FDA-Cleared HD Duodenoscope with Disposable Distal Cap

02/01/2018

Endoscopic imaging specialist PENTAX Medical has announced the U.S. launch of its new C.A.P. HD Duodenoscope (ED34-i10T), the first FDA-cleared duodenoscope with a disposable distal cap.

More...

The MedTech Forum 23rd - 25th Jan 18

19/12/2017

Remtec's CEO, Nigel Job will be attending the Medtech Forum, Brussels on the 24th - 25th January 2018.  

More...

DePuy Synthes Changes the Shape of Compression in Foot and Ankle Surgery

18/12/2017

J&J company, DePuy Synthes has launched its Continuous Compression Implants to health care providers across Europe, the Middle East and Africa (EMEA). The implants are designed to provide continuous, active compression throughout the healing process to treat a variety of reconstructive foot and ankle procedures, and provide more solutions for our patients and customers.

More...

Final NHS ‘no’ for obesity pill Mysimba

18/12/2017

An appeal to get NHS funding for Mysimba as a means for controlling weight has failed, with cost-regulators publishing final guidelines rejecting the drug.

More...

Bristol-Myers boosts I-O offering with new Ono drug deal

18/12/2017

Bristol-Myers Squibb has licensed a phase 1 immuno-oncology drug from Japan’s Ono in a $40 million upfront pact.

More...

DePuy Synthes’ EMEA Launch of CONCORDE™ Clear MIS Discectomy Device

11/12/2017

DePuy Synthes has announced the launch of CONCORDE™ Clear MIS Discectomy Device, which it says simplifies discectomy in minimally invasive spinal fusion surgery.

More...

Gilead makes bolt-on CAR-T buy after Kite deal

11/12/2017

After its $12 billion buyout of Kite this year for its new class of immuno-oncology therapy, Gilead has made a much smaller bolt-on acquisition of Cell Design with an eye to the future of CAR-T.

More...

Phillips-Medisize working with Dance Biopharm on connected insulin inhaler

11/12/2017

The companies entered into a joint development (JDA) agreement to work on a connected version of the Dance 501 inhaler. Developed by Dance Biopharm, the small handheld electronic inhaler is designed to produce consistently sized particles of liquid insulin in the form of a soft mist. The Dance 501 has not yet been approved by any regulatory authority

More...

Astellas buys DMD drug in $450M mitochondrial takeover

04/12/2017

Astellas has acquired its partner Mitobridge in a deal worth up to $450 million. The takeover gives Astellas full control of a phase 1 Duchenne muscular dystrophy (DMD) drug in return for $225 million upfront and the same again down the line.

More...

Stellar results for Novartis, Teva anti-CGRP migraine drugs

04/12/2017

Fifty percent of patients taking Novartis’ erenumab in a Phase III clinical trial had their migraine days cut by at least half, according to the data.

More...

Philips teams up with 3D Systems & Stratasys

04/12/2017

Health technology company Philips has announced that it is working together with 3D Systems and Stratasys to incorporate a 3D modelling application into clinical workflows.

More...

Identifying new ‘template’ for potent vaccine against HIV

27/11/2017

Development of an effective HIV vaccine faces many challenges not seen in other prophylaxis efforts. The virus mutates like crazy, and it knows how to cloak itself to evade our immune system, just to name two. Now, scientists at the International AIDS Vaccine Initiative (IAVI) and the Scripps Research Institute have identified certain viral changes and antibody features that could provide a possible template for vaccine design that tackles both issues.

More...

Invibio Aims to Accelerate Time-to-Market for Innovative Medical Devices

27/11/2017

Invibio Biomaterial Solutions has implemented a series of investments that it hopes will deliver demonstrable clinical outcomes, lower healthcare costs and shorter development time for innovative concepts.

More...

Janssen’s Zytiga approved for earlier use in prostate cancer

27/11/2017

European regulators are allowing earlier use of Janssen’s Zytiga in the treatment pathway for metastatic prostate cancer.

More...

Cue Biopharma in $374M-plus Merck immunotherapy pact

20/11/2017

After raising $26 million at the start of the year, cancer and autoimmune startup Cue Biopharma has ended the year with a potentially lucrative new deal with Merck.

More...

Scotland approves three new meds for NHS use

20/11/2017

The Scottish Medicines Consortium (SMC) has published new advice accepting three new medicines for use by NHS Scotland, offering patients new treatment options for soft tissue sarcoma, acromegaly and hepatitis C.

More...

Portable Transcranial Doppler Technology Can Accurately Measure Early Strokes

20/11/2017

Brain health technologist, Neural Analytics, Inc., is pointing at study results that say its transcranial doppler is 94% accurate in early identification if stroke.

More...

Medical devices could be key to the fight on antibiotic resistance

13/11/2017

Two medical devices developed by University of Birmingham researchers to help the fight against antibiotic resistance will be exhibited in the Superbugs: The Fight For Our Lives exhibition, which opens at the Science Museum in London on 9th November.

More...

NHS England, Roche come to agreement on Perjeta

13/11/2017

NHS England and Roche have agreed a confidential commercial agreement on the price of Perjeta for certain patients with breast cancer.

More...

Sanofi pays $40M, commits $765M more for preclinical MS drug

13/11/2017

Sanofi has committed up to $805 million to license multiple sclerosis drug PRN2246 from Principia Biopharma. The French Big Pharma is paying $40 million upfront to pick up the preclinical asset, with $765 million more to follow if it passes all the milestones that await.

More...

GlaxoSmithKline R&D chief Vallance to leave for government job: FT

06/11/2017

GlaxoSmithKline’s long-standing president of R&D, Patrick Vallance, is said to be standing down.

More...

AZ’ experimental asthma drug fails in Phase III

06/11/2017

An experimental therapy being developed by AstraZeneca and its biologics research and development arm MedImmune has failed to hit key targets in two Phase III trials.

More...

ObesityWeek™ 2017 Sees Ethicon Launching Bariatric Surgery App

06/11/2017

J&J device company Ethicon is partnering with J&J Health & Wellness Solutions to introduce a new digital platform and smartphone app. The idea is to offer resources and decision-making tools for patients considering weight loss surgery.

More...

High-dose Gilead/Nimbus NASH drug hits liver fat

30/10/2017

In new phase 2 data published today, Gilead says a higher dose of its NASH drug saw statistically significant reductions in liver fat, although a lower dose missed the mark.

More...

Biogen takes up option to co-develop Eisai AD drug

30/10/2017

Biogen and Eisai have expanded their existing collaboration agreement to develop and commercialise investigational therapies for Alzheimer’s Disease.

More...

J&J’s DePuy Synthes Launches Two MIS Spinal Fusion Surgery Devices

30/10/2017

As MIS gains traction and shows reduced complications compared to open surgery, DePuy Synthes is introducing two devices that are designed to simplify degenerative disc procedures.

More...

NICE nod for GSK’s ‘bubble baby syndrome’ gene therapy

24/10/2017

The National Institute for Health and Care Excellence has published draft guidance recommending GlaxoSmithKline’s gene therapy Strimvelis as an option for treating an ultra-rare immune deficiency condition commonly referred to as bubble baby syndrome.

More...

New Funding Will Fuel Claret Medical’s U.S. Plans for Sentinel® Cerebral Protection System

24/10/2017

Claret Medical® has closed a $14.5million funding round that it says will support market access programs for the Sentinel® Cerebral Protection System.

More...

AstraZeneca helps ADCT to $200M megaround to push anticancer ADCs to pivotal data

24/10/2017

ADC Therapeutics has raised $200 million (€170 million), bringing its total haul up to $455 million. The antibody-drug conjugate (ADC) specialist will use the money to take its two lead hematological cancer assets through registrational trials. 

More...

Space Station Tech Behind New Surgical Robot Arm

12/10/2017

Canadian medtech company Synaptive Medical Inc., has released Modus V™, its second-generation, high-powered digital microscope. The interesting bit is the system’s surgical robotic arm, which is derived from Canadarm technology used on the International Space Station.

More...

US Cancer Therapy Provider Elects to Adopt Elekta as Complete Solution

12/10/2017

Radiation therapy products from Elekta are to be adopted by a US cancer care service as the complete solution for its radiation oncology needs, says the company.

More...

DePuy Synthes Unveils VIPER PRIME™ MIS Pedicle Screw System at EuroSpine

12/10/2017

DePuy Synthes unveiled its new VIPER PRIME™ System during this week’s EUROSPINE 2017 congress in Dublin, Ireland. The company describes the product as an innovative, Minimally Invasive Surgery (MIS) pedicle screw designed to simplify MIS spinal fusion surgery.

More...

Green Light for BioCardia Study Following Interim Safety Analysis

05/10/2017

Cardiovascular Regenerative therapies company, BioCardia tells us that the independent Data Safety Monitoring Board (DSMB) has indicated there were no significant safety concerns with the CardiAMP study results and recommended that the trial continue, as planned.

More...

UK MedTech on a Mission in California

05/10/2017

A group comprising UK clinicians and medical technology companies have been be visiting California this week (23-29 September 2017) in a bid to forge stronger relationships across the State.

More...

Pentax Medical Europe Unveils Unique Duodenoscope with Disposable Elevator Cap

05/10/2017

Endoscopy specialist, Pentax Medical Europe has gained CE mark approval for its new duodenoscope with a Disposable Elevator Cap – the DEC™ Duodenoscope.

More...

FDA Approval and U.S. Launch of Medtronic’s New Chronic Intractable Pain Platform

26/09/2017

Medtronic plc has gained FDA approval and is now initiating the U.S. launch of its Intellis™ platform for the management of certain types of chronic intractable pain.

More...

NICE backs use of Opdivo for lung cancer

26/09/2017

Bristol-Myers Squibb’s Opdivo is being recommended by the National Institute for Health and Care Excellence to treat a certain form of lung cancer on the NHS in England, via the Cancer Drugs Fund.

More...

First biotech emerges from Garabedian’s accelerator armed with $10M, plans to tackle autoimmune diseases

26/09/2017

Chris Garabedian’s accelerator has spawned its first biotech. The startup, Landos Biopharma, has secured the support of the ex-Sarepta CEO’s Xontogeny and $10 million from Perceptive Advisors to take a LANCL2-targeted treatment for inflammatory bowel disease (IBD) into the clinic.

More...

FDA approves first cancer biosimilar

20/09/2017

The US Food and Drug Administration has approved Amgen’s Mvasi (bevacizumab-awwb) as a biosimilar to Roche/Genentech’s Avastin (bevacizumab) for the treatment of multiple types of cancer, making it the first biosimilar approved in the country for the treatment of cancer.

More...

Abbott's flash glucose monitor to be made available on NHS

18/09/2017

Abbott's FreeStyle Libre – a flash glucose monitor that allows diabetes patients to track their blood sugar without pricking – will be reimbursed by the NHS from 1 November, subject to local health economy approval.

More...

U.S. 510(K) Clearance for Adherium’s Smartinhaler for AstraZeneca’s Symbicort Aerosol

08/09/2017

The U.S. FDA has cleared Adherium’s new SmartTouch for Symbicort® inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler.

More...

Bicycle Therapeutics could net over $400m in haemophilia deal

08/09/2017

Bicycle Therapeutics has teamed up with another biotech firm in a bid to tackle haemophilia and sickle cell disease in a deal which could net it over $400m.

More...

As Britain tops global university rankings, we must get Brexit right to stay there

06/09/2017

The Times Higher Education World University Rankings have, for the first time, named Oxford and Cambridge as the world’s two top universities. ABPI’s new Head of Education and Academic Liaison, Andrew Croydon, says this latest news adds to the weight of evidence that any Brexit deal should secure the UK’s access to the best science talent and research projects around the world.

More...

Swedish researchers build new tool to test coronary artery disease risk

05/09/2017

Researchers from Uppsala University in Sweden have built a new tool to identify patients who are at high-risk of coronary artery disease and could benefit from new, intensive preventive treatments.

More...

Tox prompts Janssen to drop MacroGenics' cancer antibody

04/09/2017

Janssen is ending a license deal with MacroGenics for duvortuxizumab, a CD19- and CD3-targeting drug for B-cell malignancies it paid $125 million upfront for in 2014, but isn’t severing ties with the biotech entirely.

More...

Report lays out new strategy for UK life sciences

04/09/2017

Industry-led plans to breathe new life into the UK’s £64-billion life sciences sector have been unveiled alongside details of £160 million in government funding to fuel progress in the field.

More...

Boosting immunotherapy by targeting cells’ recycling centers

30/08/2017

A subpopulation of cells in the immune system called CD8+ T cells are vital for the proper functioning of both vaccines and cancer immunotherapy treatments. When these cells divide, they become one of two types of pathogen-destroying soldiers: those that kill right away or those that remember the offender and provide long-term protection. Finding a way to boost the second variety of immune cells, called “memory” CD8+ T cells, could improve both vaccines and immunotherapies.

More...

Convenient Blood Test Detects Circulating DNA to Identify Recurrence of Tumors

30/08/2017

QIAGEN and colorectal cancer diagnostics company Clinical Genomics, tell us they have implemented the PAXgene® Blood ccfDNA Tube* sample collection in Clinical Genomics’ Colvera™ colorectal cancer (“CRC”) recurrence assay.

More...

Novartis breast cancer drug Kisqali wins EU approval

30/08/2017

Novartis has announced the launch of its new breast cancer drug Kisqali in the UK today following a green light from European regulators.

More...

100,000th Smartinhaler™ for Adherium

23/08/2017

Adherium Limited has recently manufactured and sold it’s 100,000th Smartinhaler™.

More...

James Mullen backs Vicarius’ $22M series A to equip ex-Biogen, Elan team to offer U.S. biotechs a route to Europe

23/08/2017

James Mullen has teamed up with colleagues from his days leading Biogen to help U.S. biotechs bring drugs to market in Europe. The resulting startup has raised CHF 21 million ($22 million) to get off the ground—and plans to return for about 10 times that once its business gets up to speed.

More...

Pfizer berates NICE over ALL drug decision

23/08/2017

Pfizer has said it is "very disappointed" by NICE’s decision to not recommend inotuzumab ozogamicin as a treatment for acute lymphoblastic leukaemia (ALL) – and that it believes NICE “inappropriately assessed the value of the medicine in making their determination of cost-effectiveness, using assumptions that are inconsistent with previous appraisals of other medicines in this disease area”.

More...

Celgene drops Sutro buyout option and refocuses deal on 4 I-O programs, freeing partner to pursue new alliances, IPO

11/08/2017

Celgene and Sutro Biopharma have revised the terms of the immuno-oncology pact they entered into in 2014. The reshuffle sees Celgene secure a stake in four assets that are advancing toward the clinic and opportunities to invest in Sutro at the expense of its option to buy the biotech outright.

More...

£2m UK consortium to tackle gene therapy

11/08/2017

A new consortium, led by Oxford BioMedica, will embark on a two-year, £2 million project focused on gene and cell therapy manufacturing.

More...

FDA clears AUM’s diagnostic cardiovascular device

11/08/2017

The US Food and Drug Administration (FDA) has cleared AUM Cardiovascular’s acoustic and electrocardiogram (ECG) device called CADence to aid detection of physiological and pathological heart murmurs.

More...

Silverstein-backed startup will test gene therapy for Parkinson's

10/08/2017

Regenxbio has joined forces with investment firm OrbiMed and a new nonprofit foundation to create Prevail Therapeutics, a startup focused on new biologics and gene therapies for Parkinson's disease (PD).

More...

LimFlow Pilot Study Yields Hope for “Desert Foot”

10/08/2017

A newly published pilot study into the LimFlow pDVA system suggests it offers an alternative option for the “desert foot.”

More...

Diabetes prescriptions rocket 80 percent in a decade

08/08/2017

Growth in prescriptions for diabetes medicines is exceeding the rise in overall prescribing, according to new figures from NHS Digital.

More...

J&J Unveils New Neurovascular Business Name

02/08/2017

Sitting under the DePuy umbrella, Johnson & Johnson Medical Devices Companies has launched a new neurovascular business, to be called CERENOVUS.

More...

New hepatitis C therapies approved in Europe

02/08/2017

Patients with hepatitis C in Europe could soon gain access to two new pan-genotypic treatment options after the European Commission issued approval for AbbVie’s Maviret and Gilead’s Vosevi following an accelerated review.

More...

3 Things In Biotech You Should Learn Today:

02/08/2017

Summary AstraZeneca and Merck join forces in PARP inhibition.

More...

Gilead’s new HIV therapy under EU review

20/07/2017

European regulators are now reviewing Gilead’s fixed-dose combination of bictegravir (BIC), emtricitabine and tenofovir alafenamide as a treatment for HIV-1 infection.

More...

Breath sample cancer detection trials in Cambridge to widen

17/07/2017

Cambridge scientists will widen a cancer clinical trial to see if breath samples can be used to detect cancer in its early stages.

More...

GSK picks third target in Immunocore discovery deal

15/07/2017

GlaxoSmithKline has selected a third target in its collaboration with Oxford, UK-based Immunocore to discover multiple novel targets in cancer not addressable with antibody-based technologies.

More...

LifeArc teams up with UK defence lab and Canada’s CDRD

11/07/2017

LifeArc, the UK medical research charity previously known as MRC Technology, is working alongside the government’s Defence Science and Technology Laboratory and Canada’s Centre for Drug Research and Development (CDRD) to identify new antibacterial drug targets.

More...

GSK signs drug discovery pact with AI group Exscientia

09/07/2017

GlaxoSmithKline has signed a drug discovery pact with Dundee, UK-based artificial intelligence (AI) group Exscientia focused on multiple therapeutic areas.

More...

EU nod for Pfizer’s Besponsa

07/07/2017

Pfizer’s antibody drug conjugate Besponsa has become the first to be approved by regulators in Europe to treat some adults with the rare, aggressive cancer acute lymphoblastic leukaemia (ALL).

More...

MPs keen for close collaboration with EMA post Brexit

05/07/2017

British MPs say they are keen to secure a close working relationship with the European Union on drug regulation post Brexit to protect patient health and investment in the UK’s life sciences sector.

More...

Sandoz launches MabThera, Enbrel biosimilars in the UK

03/07/2017

Novartis group Sandoz has launched two new biosimilars across the UK potentially expanding access to biologic treatments for a range of inflammatory conditions and blood cancers.

More...

Ethicon’s New Power Stapler Delivers Control and Precision for Complex Surgeries

29/06/2017

J&J’s Ethicon has announced the launch of its ECHELON FLEX™ GST System (45mm) across Europe.

More...

Pfizer starts work on $236M biotherapeutics facility in Missouri

29/06/2017

Pfizer's biologic, vaccine and gene therapy researchers should have a new headquarters in mid-2019, now that construction work has started at a site in Chesterfield, Missouri.

More...

Joint expanded portfolio to provide integrated and seamless products and application services

29/06/2017

At the 17th Quadrennial Meeting of the World Society for Stereotactic and Functional Neurosurgery (WSSFN, June 26-29), Elekta (EKTA-B.ST) and Brainlab announced an agreement according to which Brainlab will be the authorized distributor of Elekta's stereotactic solutions for neurosurgery in selected markets.

More...

Novartis’ eye drug on par with Eylea but with fewer injections

21/06/2017

Novartis’ eye drug brolucizumab has been proven in trials to be non-inferior to Regeneron/Bayer’s Elyea in treating vision loss in patients with neovascular age-related macular degeneration (nAMD), but with fewer injections than its rival.

More...